Effects of the sodium‐glucose cotransporter 2 inhibitor dapagliflozin on fluid distribution: A comparison study with furosemide and tolvaptanKen Ohara, Daisuke Nagata, Takahiro Masuda et al.|Nephrology|2018Cited by 82
The extracellular volume status predicts body fluid response to SGLT2 inhibitor dapagliflozin in diabetic kidney diseaseKen Ohara, Daisuke Nagata, Takahiro Masuda et al.|Diabetology & Metabolic Syndrome|2020Cited by 66
Association between circulating fibroblast growth factor 21 and mortality in end-stage renal diseaseMarina Kohara, Daisuke Nagata, Takahiro Masuda et al.|PLoS ONE|2017Cited by 66
Association between Serum Soluble Klotho Levels and Mortality in Chronic Hemodialysis PatientsNaoko Otani-Takei, Daisuke Nagata, Takahiro Masuda et al.|International Journal of Endocrinology|2015Cited by 51
Dual Impact of Tolvaptan on Intracellular and Extracellular Water in Chronic Kidney Disease Patients with Fluid RetentionTakahiro Masuda, Daisuke Nagata, Takahisa Kobayashi et al.|Internal Medicine|2016Cited by 26